Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome
Bridget Charbonneau(Cedars-Sinai Medical Center), Louise A. Brinton(National Cancer Institute), Brooke L. Fridley(Children's Mercy Hospital), Julie M. Cunningham(Cancer Research UK), Weiva Sieh(The University of Texas MD Anderson Cancer Center), Zachary C. Fogarty(Mayo Clinic in Florida), Lynn C. Hartmann(Mayo Clinic), Allan Jensen(Danish Cancer Society), Jonathan P. Tyrer(University of Cambridge), Honglin Song(University of Cambridge), Robert A. Vierkant(Mayo Clinic), Jan Lubiński(Tumour Institute of Tuscany), Anna DeFazio(The University of Sydney), Thomas A. Sellers(Mayo Clinic), Andrew Berchuck(General Marble (Greece)), Aleksandra Gentry‐Maharaj(UCL Australia), Susan J. Ramus(Cancer Institute of New South Wales), Kathryn L. Terry(Brigham and Women's Hospital), Christine Walsh(Cedars-Sinai Medical Center), Ignace Vergote(KU Leuven), Matthew J. Maurer(Mayo Clinic in Arizona), Evelyn Despierre(KU Leuven), David N. Rider(Cedars-Sinai Medical Center), Kimberly R. Kalli(Mayo Clinic), Valerie McGuire(Cargill (Netherlands)), Malcolm C. Pike(Kettering University), Ann L. Oberg(University of Minnesota), Argyrios Ziogas(University of Copenhagen), Anna H. Wu(University of Southern California), Kate Lawrenson(Texas A&M University – San Antonio), Jennifer A. Doherty(Cancer Prevention Institute of California), Montserrat García‐Closas(Institute of Cancer Research), Claudia C. Preston(Cedars-Sinai Medical Center), Hannah Yang(Cancer Prevention Institute of California), David Van Den Berg(University of Southern California), Cezary Cybulski(International Hereditary Cancer Center), Krista M. Goergen(Mayo Clinic in Florida), Brenda Diergaarde(University of Pittsburgh), Chen Wang(Xiamen University), Starr M. Ramirez(Cedars-Sinai Medical Center), Catherine M. Phelan(University of Southern California), Sharon E. Johnatty(University of Southern California), Allison F. Vitonis(Brigham and Women's Hospital), Jenny Lester(Cedars-Sinai Medical Center), Sandrina Lambrechts(Dartmouth College), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Joseph H. Rothstein(University of Washington Medical Center), Matthew S. Block(Mayo Clinic in Arizona), Howard C. Shen(University of Southern California), Janusz Menkiszak(Pomeranian Medical University)
Cited by 27
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k